US 9102666
Methods and drug products for treating Alzheimer's disease
granted A61KA61K31/4439A61P
Quick answer
US patent 9102666 (Methods and drug products for treating Alzheimer's disease) held by Takeda Pharmaceutical Company Limited expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/4439, A61P, A61P25/00, A61P25/28